Cite
APA Citation
Halatsch, M., Kast, R. E., Dwucet, A., Hlavac, M., Heiland, T., Westhoff, M., Debatin, K., Wirtz, C. R., Siegelin, M. D., & Karpel‐Massler, G. (2019). bcl‐2/Bcl‐xL inhibition predominantly synergistically enhances the anti‐neoplastic activity of a low‐dose CUSP9 repurposed drug regime against glioblastoma. British journal of pharmacology, 176, 3681–3694. http://access.bl.uk/ark:/81055/vdc_100091263409.0x00005c